The administration of highly active antiretroviral therapy (HAART) has produced a significant decrease in acquired immunodeficiency syndrome–related opportunistic infections, but also has changed the natural history and the usual presentation of some of these infections.1- 4 Soon after the introduction of combination regimens that included protease inhibitors, several researchers reported unusual clinical features in patients who developed opportunistic diseases after the initiation of HAART. The new clinical features have been well described for disseminated Mycobacterium avium complex disease5 and for cytomegalovirus retinitis,6 and were given the generic name of "reactivation syndrome" or "immune reconstitution syndrome." This syndrome was attributed to the immunologic recovery produced by HAART, which could enhance the inflammatory response around the infection, producing either a relapse of clinical symptoms or the appearance of new-onset opportunistic infections.7
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 95
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Care at the Close of Life EDUCATION GUIDESOvercoming the False Dichotomy of Curative vs Palliative Care for Late-Stage HIV/AIDS
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.